普洛药业：公司丁二磺酸腺苷蛋氨酸肠溶片于2024年11月获批

Core Viewpoint - The company, Prolo Pharmaceutical, announced that its drug, Dihydrosulfonic Acid Adenosylmethionine Enteric-Coated Tablets, is expected to be approved in November 2024 and is currently expanding its market presence in the Beijing-Tianjin-Hebei "3+N" alliance and Guangdong alliance [1] Group 1 - The drug is set to receive approval in November 2024 [1] - The company has already won bids in the Beijing-Tianjin-Hebei "3+N" alliance and Guangdong alliance [1] - The company is in the process of rapidly expanding its market [1]